Recent Finacing
Recent Raise
Arcturus Therapeutics develops mRNA therapeutics using LUNAR lipid‑nanoparticle delivery and UNA chemistry, including inhaled LUNAR-CF to deliver CFTR mRNA to lung epithelial cells via nebulization.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investor
See the team members at Arcturus Therapeutics.
